Supreme Court To Consider Prometheus Patents On Method Of Calibrating Drug Dosage
This article was originally published in The Pink Sheet Daily
Executive Summary
Mayo contends Prometheus patents cover a natural phenomenon.
You may also be interested in...
Personalized Medicine At Stake In Prometheus Patent Case, BIO Tells Supreme Court
The biotech and pharmaceutical industries oppose a broad ruling that would prevent patenting of medical processes and diagnostics. Mayo is challenging patents on the correlation between drug metabolites and proper dosage.
Is A Pharma Sales Rep A Salesman? Supreme Court To Make Final Call
Court to decide whether sales reps qualify for overtime pay in case involving former GlaxoSmithKline reps; it is the third pharma case this term.
Eligible, But Probably Obvious: Prometheus Patents Critiqued In Government's Amicus Brief
The Solicitor General tells the Supreme Court that Prometheus' patents on a process for determining the proper dose of thiopurine drugs should have included "concrete treatment steps."